Volltextsuche
Hinweis: Bitte geben Sie einen Suchbegriff ein, z.B. "BMW", um alle Analysen und News über BMW aufgelistet zu bekommen, die innerhalb der Site von AktienCheck vorhanden sind! Zusätzlich können Sie noch eine Zeitspanne auswählen.
Suchergebnisse: (33676 Ergebnisse gefunden) Es w.
| Datum | Thema | |
|---|---|---|
| 18.04.26 | Redwood AI Aktie: Strategische Offensive | |
| Redwood AI dehnt sein Geschäftsmodell auf den Bereich der öffentlichen Sicherheit aus. In British Columbia startet das Unternehmen eine zweijährige Kooperation mit Aidos Innovations, um die dortige Fentanyl-Krise mit künstlicher Intelligenz zu bekämpfen. Die Partnerschaft zielt darauf ab, die Lieferketten toxischer Opioide mittels prädiktiver Analysen zu zerschlagen. [...] | ||
| 18.04.26 | Barrick Mining's Strategic Pivot Confronts Market Skepticism | |
| Barrick Mining's stock is telling a different story than the gold market. While the precious metal trades above $4,500 an ounce, the company's shares closed the week at CAD 58.16, down 3.5% from the prior week and roughly 3% lower year-to-date. This disconnect highlights the complex operational and strategic challenges facing the miner, even as commodity prices provide a powerful tailwind. [...] | ||
| 18.04.26 | DroneShield Navigates a Leadership Transition on a Record Run | |
| The stock of counter-drone specialist DroneShield is caught between two powerful narratives. On one side sits a historic operational performance, marked by exploding revenue and a multi-billion dollar sales pipeline. On the other, a recent and sudden change in the company's leadership has introduced a layer of uncertainty for investors trying to gauge its future trajectory. [...] | ||
| 18.04.26 | ABO Energy's Technical Breakout Tests a Foundation of Losses | |
| A sudden surge in ABO Energy's share price last week offered a flicker of hope to investors, but the move only underscores the profound depths from which the renewable developer must climb. The stock closed Friday at €5.82, having decisively broken above its 50-day moving average of €5.73 the previous day. [...] | ||
| 17.04.26 | Sow Good Inc. Announces Reverse Stock Split | |
| IRVING, Texas, April 17, 2026 (GLOBE NEWSWIRE) -- Sow Good Inc. (NASDAQ: SOWG), a freeze-dried food and candy manufacturer, announced today that its Board of Directors has approved a 15-to-1 reverse stock split (the “reverse stock split”), of its common stock, par value $0.001 (the “Common Stock”), effective at 5:00 pm Eastern Time on April 23, 2026 (the “Effective Time”). [...] | ||
| 17.04.26 | Japan Smaller Capitalization Fund, Inc. Announces Board Determination to Proceed with Conditional Tender Offer | |
| CONDITIONAL TENDER OFFER FOR 10% OF OUTSTANDING SHARES. [...] | ||
| 17.04.26 | Sysco Declares Increase to Quarterly Dividend Payment | |
| HOUSTON, April 17, 2026 (GLOBE NEWSWIRE) -- Sysco Corporation (NYSE:SYY) today announced that its Board of Directors declared a quarterly cash dividend of $0.55 per share, representing a $0.01 increase from the prior quarterly dividend of $0.54 per share. The new dividend is payable for the first . [...] | ||
| 17.04.26 | Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | |
| WALTHAM, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for patients living with autoimmune. [...] | ||
| 17.04.26 | CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | |
| CAMBRIDGE, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of rest. [...] | ||
| 17.04.26 | 4DMT Announces New Employment Inducement Grants | |
| EMERYVILLE, Calif., April 17, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that on April 14, 2026, the compensation committee of the Company’s board of directors granted five new non-executive employees 67,600 Restricted Stock Units (RSUs). [...] |
